Serge Belanger
Stock Analyst at Needham
(4.58)
# 201
Out of 5,182 analysts
406
Total ratings
55.24%
Success rate
22.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Maintains: Buy | $14 → $15 | $7.59 | +97.63% | 22 | Apr 27, 2026 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $42 → $32 | $13.47 | +137.65% | 21 | Mar 30, 2026 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $35 → $36 | $19.14 | +88.09% | 25 | Mar 25, 2026 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $54 → $56 | $32.76 | +70.94% | 29 | Mar 19, 2026 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $22 → $24 | $13.94 | +72.17% | 23 | Mar 18, 2026 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $58 → $80 | $54.12 | +47.82% | 15 | Mar 9, 2026 | |
| LQDA Liquidia | Maintains: Buy | $52 → $54 | $36.74 | +46.98% | 36 | Mar 5, 2026 | |
| OCS Oculis Holding AG | Maintains: Buy | $36 → $40 | $27.16 | +47.28% | 3 | Mar 4, 2026 | |
| ESPR Esperion Therapeutics | Maintains: Buy | $4 → $5 | $1.93 | +159.74% | 21 | Mar 3, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $34 → $30 | $21.88 | +37.11% | 9 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $23.28 | +54.64% | 25 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $16.89 | +48.02% | 16 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $62.50 | +36.00% | 27 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $9.29 | +93.76% | 7 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $28.86 | +66.32% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $25.39 | +18.16% | 29 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.28 | - | 17 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.92 | +101.79% | 18 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.33 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.23 | +143.90% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.61 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.42 | - | 1 | Mar 31, 2022 |
CorMedix
Apr 27, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $7.59
Upside: +97.63%
Viridian Therapeutics
Mar 30, 2026
Maintains: Buy
Price Target: $42 → $32
Current: $13.47
Upside: +137.65%
KalVista Pharmaceuticals
Mar 25, 2026
Maintains: Buy
Price Target: $35 → $36
Current: $19.14
Upside: +88.09%
Collegium Pharmaceutical
Mar 19, 2026
Reiterates: Buy
Price Target: $54 → $56
Current: $32.76
Upside: +70.94%
Trevi Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $22 → $24
Current: $13.94
Upside: +72.17%
Xenon Pharmaceuticals
Mar 9, 2026
Maintains: Buy
Price Target: $58 → $80
Current: $54.12
Upside: +47.82%
Liquidia
Mar 5, 2026
Maintains: Buy
Price Target: $52 → $54
Current: $36.74
Upside: +46.98%
Oculis Holding AG
Mar 4, 2026
Maintains: Buy
Price Target: $36 → $40
Current: $27.16
Upside: +47.28%
Esperion Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $1.93
Upside: +159.74%
Amphastar Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $30
Current: $21.88
Upside: +37.11%
Feb 26, 2026
Maintains: Buy
Price Target: $31 → $36
Current: $23.28
Upside: +54.64%
Feb 26, 2026
Reiterates: Buy
Price Target: $25
Current: $16.89
Upside: +48.02%
Feb 25, 2026
Maintains: Buy
Price Target: $84 → $85
Current: $62.50
Upside: +36.00%
Feb 20, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $9.29
Upside: +93.76%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $48
Current: $28.86
Upside: +66.32%
Jan 9, 2026
Maintains: Buy
Price Target: $30
Current: $25.39
Upside: +18.16%
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.28
Upside: -
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.92
Upside: +101.79%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.33
Upside: -
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.23
Upside: +143.90%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.61
Upside: -
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.42
Upside: -